LONDON (Sputnik) – The United Kingdom’s National Health Service (NHS) announced on Friday that trials of a revolutionary blood test developed by US company Grail to identify 50 types of cancer will begin in England in mid-2021.
WP2Social Auto Publish Powered By : XYZScripts.com